APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Therapy CDMO Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cell Therapy CDMO Services Industry Growth and Trends Forecast to 2032

12 August 2026111 pages

Choose your research edition.

Industry ResearchCell Therapy CDMO Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Therapy CDMO Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Cell Therapy CDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Therapy CDMO Services Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Therapy CDMO Services Market Analysis and Forecast 2026-2032185 pages · $4,950 USD

Market perspective

According to APO Research, the global Cell Therapy CDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cell Therapy CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cell Therapy CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell Therapy CDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cell Therapy CDMO Services market include Thermo Fisher Scientific, Wuxi AppTec, Lonza, KBI Biopharma, RoslinCT, Cell and Gene Therapy Catapult, Cell Therapies, Minaris Regenerative Medicine and MEDINET, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cell Therapy CDMO Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cell Therapy CDMO Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Therapy CDMO Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Therapy CDMO Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cell Therapy CDMO Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cell Therapy CDMO Services Market by Company

Thermo Fisher Scientific

Wuxi AppTec

Lonza

KBI Biopharma

RoslinCT

Cell and Gene Therapy Catapult

Cell Therapies

Minaris Regenerative Medicine

MEDINET

Catalent Biologics

Oxford BioMedica

GenScript

Cell-Easy

SK pharmteco

Charles River Laboratories

AGC Biologics

FUJIFILM Cellular Dynamics

Cell Therapy CDMO Services Segment by Type

Preclinical Stage

Clinical Commercialization Stage

Cell Therapy CDMO Services Segment by Application

Pharmaceutical Company

Research Institute

Cell Therapy CDMO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy CDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy CDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy CDMO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cell Therapy CDMO Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cell Therapy CDMO Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cell Therapy CDMO Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cell Therapy CDMO Services Market Share by Region (2021-2026) Table 4. Global Cell Therapy CDMO Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cell Therapy CDMO Services Market Share by Region (2027-2032) Table 6. Global Cell Therapy CDMO Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cell Therapy CDMO Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cell Therapy CDMO Services Market Size Share by Type (2021-2026) Table 9. Global Cell Therapy CDMO Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cell Therapy CDMO Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cell Therapy CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cell Therapy CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cell Therapy CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cell Therapy CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cell Therapy CDMO Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cell Therapy CDMO Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cell Therapy CDMO Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cell Therapy CDMO Services Market Size Share by Application (2021-2026) Table 24. Global Cell Therapy CDMO Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cell Therapy CDMO Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cell Therapy CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cell Therapy CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cell Therapy CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cell Therapy CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cell Therapy CDMO Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cell Therapy CDMO Services Industry Trends Table 37. Cell Therapy CDMO Services Industry Drivers Table 38. Cell Therapy CDMO Services Industry Opportunities and Challenges Table 39. Cell Therapy CDMO Services Industry Restraints Table 40. Global Cell Therapy CDMO Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cell Therapy CDMO Services Revenue Market Share by Company (2021-2026) Table 42. Global Cell Therapy CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cell Therapy CDMO Services Key Company Headquarters & Area Served Table 44. Global Cell Therapy CDMO Services Company, Product Type & Application Table 45. Global Cell Therapy CDMO Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cell Therapy CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Cell Therapy CDMO Services Product Portfolio Table 52. Thermo Fisher Scientific Recent Development Table 53. Wuxi AppTec Company Information Table 54. Wuxi AppTec Business Overview Table 55. Wuxi AppTec Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Wuxi AppTec Cell Therapy CDMO Services Product Portfolio Table 57. Wuxi AppTec Recent Development Table 58. Lonza Company Information Table 59. Lonza Business Overview Table 60. Lonza Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Lonza Cell Therapy CDMO Services Product Portfolio Table 62. Lonza Recent Development Table 63. KBI Biopharma Company Information Table 64. KBI Biopharma Business Overview Table 65. KBI Biopharma Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. KBI Biopharma Cell Therapy CDMO Services Product Portfolio Table 67. KBI Biopharma Recent Development Table 68. RoslinCT Company Information Table 69. RoslinCT Business Overview Table 70. RoslinCT Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. RoslinCT Cell Therapy CDMO Services Product Portfolio Table 72. RoslinCT Recent Development Table 73. Cell and Gene Therapy Catapult Company Information Table 74. Cell and Gene Therapy Catapult Business Overview Table 75. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Portfolio Table 77. Cell and Gene Therapy Catapult Recent Development Table 78. Cell Therapies Company Information Table 79. Cell Therapies Business Overview Table 80. Cell Therapies Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Cell Therapies Cell Therapy CDMO Services Product Portfolio Table 82. Cell Therapies Recent Development Table 83. Minaris Regenerative Medicine Company Information Table 84. Minaris Regenerative Medicine Business Overview Table 85. Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Minaris Regenerative Medicine Cell Therapy CDMO Services Product Portfolio Table 87. Minaris Regenerative Medicine Recent Development Table 88. MEDINET Company Information Table 89. MEDINET Business Overview Table 90. MEDINET Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. MEDINET Cell Therapy CDMO Services Product Portfolio Table 92. MEDINET Recent Development Table 93. Catalent Biologics Company Information Table 94. Catalent Biologics Business Overview Table 95. Catalent Biologics Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Catalent Biologics Cell Therapy CDMO Services Product Portfolio Table 97. Catalent Biologics Recent Development Table 98. Oxford BioMedica Company Information Table 99. Oxford BioMedica Business Overview Table 100. Oxford BioMedica Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Oxford BioMedica Cell Therapy CDMO Services Product Portfolio Table 102. Oxford BioMedica Recent Development Table 103. GenScript Company Information Table 104. GenScript Business Overview Table 105. GenScript Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. GenScript Cell Therapy CDMO Services Product Portfolio Table 107. GenScript Recent Development Table 108. Cell-Easy Company Information Table 109. Cell-Easy Business Overview Table 110. Cell-Easy Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cell-Easy Cell Therapy CDMO Services Product Portfolio Table 112. Cell-Easy Recent Development Table 113. SK pharmteco Company Information Table 114. SK pharmteco Business Overview Table 115. SK pharmteco Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. SK pharmteco Cell Therapy CDMO Services Product Portfolio Table 117. SK pharmteco Recent Development Table 118. Charles River Laboratories Company Information Table 119. Charles River Laboratories Business Overview Table 120. Charles River Laboratories Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Charles River Laboratories Cell Therapy CDMO Services Product Portfolio Table 122. Charles River Laboratories Recent Development Table 123. AGC Biologics Company Information Table 124. AGC Biologics Business Overview Table 125. AGC Biologics Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AGC Biologics Cell Therapy CDMO Services Product Portfolio Table 127. AGC Biologics Recent Development Table 128. FUJIFILM Cellular Dynamics Company Information Table 129. FUJIFILM Cellular Dynamics Business Overview Table 130. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Portfolio Table 132. FUJIFILM Cellular Dynamics Recent Development Table 133. North America Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Cell Therapy CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Cell Therapy CDMO Services Market Share by Country (2021-2026) Table 136. North America Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Cell Therapy CDMO Services Market Share Forecast by Country (2027-2032) Table 138. Europe Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Cell Therapy CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Cell Therapy CDMO Services Market Share by Country (2021-2026) Table 141. Europe Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Cell Therapy CDMO Services Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Cell Therapy CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Cell Therapy CDMO Services Market Share by Country (2021-2026) Table 146. Asia-Pacific Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Cell Therapy CDMO Services Market Share Forecast by Country (2027-2032) Table 148. Latin America Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Cell Therapy CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Cell Therapy CDMO Services Market Share by Country (2021-2026) Table 151. Latin America Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Cell Therapy CDMO Services Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Cell Therapy CDMO Services Market Share by Country (2021-2026) Table 156. Middle East & Africa Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Cell Therapy CDMO Services Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cell Therapy CDMO Services Product Image Figure 3. Global Cell Therapy CDMO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cell Therapy CDMO Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Cell Therapy CDMO Services Market Share by Region: 2025 VS 2032 Figure 6. Global Cell Therapy CDMO Services Market Share by Region (2021-2032) Figure 7. North America Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Preclinical Stage Image Figure 13. Global Preclinical Stage Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Clinical Commercialization Stage Image Figure 15. Global Clinical Commercialization Stage Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Cell Therapy CDMO Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Cell Therapy CDMO Services Market Share by Type 2025 VS 2032 Figure 18. North America Cell Therapy CDMO Services Market Size Share by Type (2021-2032) Figure 19. Europe Cell Therapy CDMO Services Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Cell Therapy CDMO Services Market Size Share by Type (2021-2032) Figure 21. Latin America Cell Therapy CDMO Services Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Cell Therapy CDMO Services Market Size Share by Type (2021-2032) Figure 23. Pharmaceutical Company Image Figure 24. Global Pharmaceutical Company Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Research Institute Image Figure 26. Global Research Institute Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Cell Therapy CDMO Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cell Therapy CDMO Services Market Share by Application 2025 VS 2032 Figure 29. North America Cell Therapy CDMO Services Market Size Share by Application (2021-2032) Figure 30. Europe Cell Therapy CDMO Services Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Cell Therapy CDMO Services Market Size Share by Application (2021-2032) Figure 32. Latin America Cell Therapy CDMO Services Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Cell Therapy CDMO Services Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Cell Therapy CDMO Services Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Cell Therapy CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Cell Therapy CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Cell Therapy CDMO Services Market Share by Country (2021-2032) Figure 39. Europe Cell Therapy CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Cell Therapy CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Cell Therapy CDMO Services Market Share by Country (2021-2032) Figure 42. Asia-Pacific Cell Therapy CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Cell Therapy CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Cell Therapy CDMO Services Market Share by Country (2021-2032) Figure 45. Latin America Cell Therapy CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Cell Therapy CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Cell Therapy CDMO Services Market Share by Country (2021-2032) Figure 48. Middle East & Africa Cell Therapy CDMO Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Cell Therapy CDMO Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Cell Therapy CDMO Services Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical Stage
  • Clinical Commercialization Stage
Applications
  • Pharmaceutical Company
  • Research Institute
Companies covered
  • Thermo Fisher Scientific
  • Wuxi AppTec
  • Lonza
  • KBI Biopharma
  • RoslinCT
  • Cell and Gene Therapy Catapult
  • Cell Therapies
  • Minaris Regenerative Medicine
  • MEDINET
  • Catalent Biologics
  • Oxford BioMedica
  • GenScript
  • Cell-Easy
  • SK pharmteco
  • Charles River Laboratories
  • AGC Biologics
  • FUJIFILM Cellular Dynamics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cell Therapy CDMO Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cell Therapy CDMO Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Cell Therapy CDMO Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Cell Therapy CDMO Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cell Therapy CDMO Services Market Size (2021-2032)
  8. 1.5.1 North America Cell Therapy CDMO Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cell Therapy CDMO Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cell Therapy CDMO Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate (2021-2032)
2 Cell Therapy CDMO Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Preclinical Stage
  3. 2.1.2 Clinical Commercialization Stage
  4. 2.2 Global Cell Therapy CDMO Services Market Size by Type
  5. 2.2.1 Global Cell Therapy CDMO Services Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cell Therapy CDMO Services Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cell Therapy CDMO Services Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cell Therapy CDMO Services Market Size by Regions
  9. 2.3.1 North America Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cell Therapy CDMO Services Market Size Breakdown by Type (2021-2026)
3 Cell Therapy CDMO Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical Company
  3. 3.1.2 Research Institute
  4. 3.2 Global Cell Therapy CDMO Services Market Size by Application
  5. 3.2.1 Global Cell Therapy CDMO Services Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Cell Therapy CDMO Services Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Cell Therapy CDMO Services Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Cell Therapy CDMO Services Market Size by Regions
  9. 3.3.1 North America Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Cell Therapy CDMO Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cell Therapy CDMO Services Industry Trends
  2. 4.2 Cell Therapy CDMO Services Industry Drivers
  3. 4.3 Cell Therapy CDMO Services Industry Opportunities and Challenges
  4. 4.4 Cell Therapy CDMO Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cell Therapy CDMO Services Revenue (2021-2026)
  2. 5.2 Global Cell Therapy CDMO Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cell Therapy CDMO Services Key Company Headquarters & Area Served
  4. 5.4 Global Cell Therapy CDMO Services Company, Product Type & Application
  5. 5.5 Global Cell Therapy CDMO Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cell Therapy CDMO Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cell Therapy CDMO Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cell Therapy CDMO Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Cell Therapy CDMO Services Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Wuxi AppTec
  8. 6.2.1 Wuxi AppTec Company Information
  9. 6.2.2 Wuxi AppTec Business Overview
  10. 6.2.3 Wuxi AppTec Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Wuxi AppTec Cell Therapy CDMO Services Product Portfolio
  12. 6.2.5 Wuxi AppTec Recent Developments
  13. 6.3 Lonza
  14. 6.3.1 Lonza Company Information
  15. 6.3.2 Lonza Business Overview
  16. 6.3.3 Lonza Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Lonza Cell Therapy CDMO Services Product Portfolio
  18. 6.3.5 Lonza Recent Developments
  19. 6.4 KBI Biopharma
  20. 6.4.1 KBI Biopharma Company Information
  21. 6.4.2 KBI Biopharma Business Overview
  22. 6.4.3 KBI Biopharma Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 KBI Biopharma Cell Therapy CDMO Services Product Portfolio
  24. 6.4.5 KBI Biopharma Recent Developments
  25. 6.5 RoslinCT
  26. 6.5.1 RoslinCT Company Information
  27. 6.5.2 RoslinCT Business Overview
  28. 6.5.3 RoslinCT Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 RoslinCT Cell Therapy CDMO Services Product Portfolio
  30. 6.5.5 RoslinCT Recent Developments
  31. 6.6 Cell and Gene Therapy Catapult
  32. 6.6.1 Cell and Gene Therapy Catapult Company Information
  33. 6.6.2 Cell and Gene Therapy Catapult Business Overview
  34. 6.6.3 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cell and Gene Therapy Catapult Cell Therapy CDMO Services Product Portfolio
  36. 6.6.5 Cell and Gene Therapy Catapult Recent Developments
  37. 6.7 Cell Therapies
  38. 6.7.1 Cell Therapies Company Information
  39. 6.7.2 Cell Therapies Business Overview
  40. 6.7.3 Cell Therapies Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Cell Therapies Cell Therapy CDMO Services Product Portfolio
  42. 6.7.5 Cell Therapies Recent Developments
  43. 6.8 Minaris Regenerative Medicine
  44. 6.8.1 Minaris Regenerative Medicine Company Information
  45. 6.8.2 Minaris Regenerative Medicine Business Overview
  46. 6.8.3 Minaris Regenerative Medicine Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Minaris Regenerative Medicine Cell Therapy CDMO Services Product Portfolio
  48. 6.8.5 Minaris Regenerative Medicine Recent Developments
  49. 6.9 MEDINET
  50. 6.9.1 MEDINET Company Information
  51. 6.9.2 MEDINET Business Overview
  52. 6.9.3 MEDINET Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 MEDINET Cell Therapy CDMO Services Product Portfolio
  54. 6.9.5 MEDINET Recent Developments
  55. 6.10 Catalent Biologics
  56. 6.10.1 Catalent Biologics Company Information
  57. 6.10.2 Catalent Biologics Business Overview
  58. 6.10.3 Catalent Biologics Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Catalent Biologics Cell Therapy CDMO Services Product Portfolio
  60. 6.10.5 Catalent Biologics Recent Developments
  61. 6.11 Oxford BioMedica
  62. 6.11.1 Oxford BioMedica Company Information
  63. 6.11.2 Oxford BioMedica Business Overview
  64. 6.11.3 Oxford BioMedica Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Oxford BioMedica Cell Therapy CDMO Services Product Portfolio
  66. 6.11.5 Oxford BioMedica Recent Developments
  67. 6.12 GenScript
  68. 6.12.1 GenScript Company Information
  69. 6.12.2 GenScript Business Overview
  70. 6.12.3 GenScript Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 GenScript Cell Therapy CDMO Services Product Portfolio
  72. 6.12.5 GenScript Recent Developments
  73. 6.13 Cell-Easy
  74. 6.13.1 Cell-Easy Company Information
  75. 6.13.2 Cell-Easy Business Overview
  76. 6.13.3 Cell-Easy Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cell-Easy Cell Therapy CDMO Services Product Portfolio
  78. 6.13.5 Cell-Easy Recent Developments
  79. 6.14 SK pharmteco
  80. 6.14.1 SK pharmteco Company Information
  81. 6.14.2 SK pharmteco Business Overview
  82. 6.14.3 SK pharmteco Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 SK pharmteco Cell Therapy CDMO Services Product Portfolio
  84. 6.14.5 SK pharmteco Recent Developments
  85. 6.15 Charles River Laboratories
  86. 6.15.1 Charles River Laboratories Company Information
  87. 6.15.2 Charles River Laboratories Business Overview
  88. 6.15.3 Charles River Laboratories Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Charles River Laboratories Cell Therapy CDMO Services Product Portfolio
  90. 6.15.5 Charles River Laboratories Recent Developments
  91. 6.16 AGC Biologics
  92. 6.16.1 AGC Biologics Company Information
  93. 6.16.2 AGC Biologics Business Overview
  94. 6.16.3 AGC Biologics Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AGC Biologics Cell Therapy CDMO Services Product Portfolio
  96. 6.16.5 AGC Biologics Recent Developments
  97. 6.17 FUJIFILM Cellular Dynamics
  98. 6.17.1 FUJIFILM Cellular Dynamics Company Information
  99. 6.17.2 FUJIFILM Cellular Dynamics Business Overview
  100. 6.17.3 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 FUJIFILM Cellular Dynamics Cell Therapy CDMO Services Product Portfolio
  102. 6.17.5 FUJIFILM Cellular Dynamics Recent Developments
7 North America
  1. 7.1 North America Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cell Therapy CDMO Services Market Size by Country (2021-2026)
  3. 7.3 North America Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cell Therapy CDMO Services Market Size by Country (2021-2026)
  3. 8.3 Europe Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cell Therapy CDMO Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cell Therapy CDMO Services Market Size by Country (2021-2026)
  3. 10.3 South America Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cell Therapy CDMO Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cell Therapy CDMO Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cell Therapy CDMO Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst